CRISIS I is a prospective, multicenter, randomized controlled trial, to asses the impact of intensive blood pressure control on clinical outcome of acute ischemic stroke patients with successful recanalization after endovascular therapy.
CRISIS I aims to determine the effectiveness of more intensive BP lowering target (\<120 mmHg) compared to standard BP management target (\<140mmHg) on functional outcome in patients with successful recanalization post-MT for AIS due to anterior circulation large vessel occlusion (LVO).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
205
The aim is to achieve a systolic BP level of \<120mmHg within 1hour after successful recanalization and to maintain this BP level for the next 72 hours (or until hospital discharge or death of this should occur earlier)
Nanjing First Hospital, Nanjing Medical University
Nanjing, Jiangsu, China
Level of disability
a shift (improvement) in scores (0-6) on the modified Rankin scale
Time frame: 90 days (3months)
Intracerebral hemorrhage
Any or symptomatic ICH (sICH) after endovascular therapy
Time frame: 90 day
Death or neurological severity
Death or dependency measured by National Institutes of Health stroke scale (NIHSS)
Time frame: 7 days
BP lowering target (<120 mmHg)
Time frame: 3 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.